JHSM

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

EndNote Style
Index
Original Article
The role of disease activity as a determinant of body awareness and central sensitization in patients with axial spondyloarthritis: a cross-sectional study
Aims: The aim of this study was to investigate the effects of disease activity on body awareness and central sensitization in patients with axial spondyloarthritis (axSpA).
Methods: This cross-sectional study included patients diagnosed with axSpA. Disease activity was evaluated using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and a score of four or higher was considered high disease activity. Patients were divided into two groups according to BASDAI: high disease activity (BASDAI ? 4) group (HG) and the low disease activity (BASDAI<4) group (LG). Body awareness levels were assessed with the Body Awareness Questionnaire (BAQ). The Central Sensitization Inventory (CSI) was used for central sensitivity. Simple linear regression analyses were performed to investigate which of the independent variables could explain the disease activity.
Results: Sixty-two patients with a mean disease duration of 10.8 years were included. The mean BASDAI, CSI-A, and BAQ were 4.2, 38.5, and 73 points, respectively. Demographics and clinical characteristics were comparable between the groups (p>0.05). The CSI-A score was higher in HG compared to LG (44 (31-54) vs. 31 (21-41), p=0.008). The HG had poorer BAQ scores than the LG (61 (52-85) vs. 85 (64-96), p=0.017). BASDAI was moderately associated with CSI-A (r=0.145, R2=0.172, p=0.001). No significant correlation was found between BASDAI and BAQ (p=0.167). The results of the simple linear regression analysis suggested that CSI-A explained 17.2% of the disease activity. BASDAI (ß = 0.415, p=0.001) significantly predicted central sensitization. BASDAI was strongly correlated with VAS (r=0.665, R2= 0.442, p<0.001). The VAS explained 44.2% of the disease activity, and BASDAI (r=0.665, p<0.001) significantly predicted pain severity.
Conclusion: High disease activity adversely affects central sensitization and body awareness in patients with axSpA. Physicians should also consider a multimodal biopsychosocial perspective in the management of patients with high disease activity.


1. Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet.2017;390(10089):73-84. doi:10.1016/s0140-6736(16)31591-4
2. Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosingspondylitis: an overview. Ann Rheum Dis. 2002;61 Suppl 3(Suppl3):iii8-18. doi:10.1136/ard.61.suppl_3.iii8
3. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P,Calin A. A new approach to defining disease status in ankylosingspondylitis: the bath ankylosing spondylitis disease activity index.J Rheumatol. 1994;21(12):2286-2291.
4. Bas DB, Su J, Wigerblad G, Svensson CI. Pain in rheumatoidarthritis: models and mechanisms. Pain Manag. 2016;6(3):265-284. doi:10.2217/pmt.16.4
5. Loeser JD, Treede RD. The Kyoto protocol of IASP basic painterminology. Pain. 2008;137(3):473-477. doi:10.1016/j.pain.2008.04.025
6. Kieskamp SC, Paap D, Carbo MJG, et al. Central sensitization,illness perception and obesity should be considered wheninterpreting disease activity in axial spondyloarthritis.Rheumatology (Oxford). 2021;60(10):4476-4485. doi:10.1093/rheumatology/keab019
7. Arends S, Brouwer E, Efde M, et al. Long-term drug survivaland clinical effectiveness of etanercept treatment in patientswith ankylosing spondylitis in daily clinical practice. Clin ExpRheumatol. 2017;35(1):61-68.
8. Baskan E, Yagci N, Cavlak U. Factors affecting body awarenessin older adults with chronic musculoskeletal pain. Arch Med Sci.2021;17(4):934-939. doi:10.5114/aoms.2019.86614
9. Kalkışım ŞN, Erden A, Kanber Uzun &Ouml;, Ertemoğlu &Ouml;ks&uuml;z C,Zihni NB, &Ccedil;an MA. Relationship between body awarenesslevel and musculoskeletal pain complaints, physical activitylevel and emotional status in healthy people. Acta Neurol Belg.2023;123:1789-1796. doi:10.1007/s13760-022-02056-2
10. Baas LS, Beery TA, Allen G, Wizer M, Wagoner LE. Anexploratory study of body awareness in persons with heart failuretreated medically or with transplantation. J Cardiovasc Nurs.2004;19(1):32-40. doi:10.1097/00005082-200401000-00007
11. Bekker MH, Croon MA, Van Balkom EG, Vermee JB. Predictingindividual differences in autonomy-connectedness: the role ofbody awareness, alexithymia, and assertiveness. J Clin Psychol.2008;64(6):747-765. doi:10.1002/jclp.20486
12. Durlik C, Cardini F, Tsakiris M. Being watched: the effect of socialself-focus on interoceptive and exteroceptive somatosensoryperception. Conscious Cogn. 2014;25:42-50. doi:10.1016/j.concog.2014.01.010
13. Gyllensten AL, Hui-Chan CW, Tsang WW. Stability limits, single-leg jump, and body awareness in older Tai Chi practitioners.Arch Phys Med Rehabil. 2010;91(2):215-20. doi:10.1016/j.apmr.2009.10.009
14. Erden A, Altuğ F, Cavlak U. Investigation of the relationshipbetween body awareness, pain, emotional status, and quality of lifeamong healthy people. J Kartal Train Res Hosp. 2013;24(3):145-150.
15. Bantick SJ, Wise RG, Ploghaus A, Clare S, Smith SM, Tracey I.Imaging how attention modulates pain in humans using functionalMRI. Brain. 2002;125(Pt 2):310-319. doi:10.1093/brain/awf022
16. Johnson MH. How does distraction work in the managementof pain? Curr Pain Headache Rep. 2005;9(2):90-95. doi:10.1007/s11916-005-0044-1
17. Burns JW. The role of attentional strategies in moderating linksbetween acute pain induction and subsequent psychological stress:evidence for symptom-specific reactivity among patients withchronic pain versus healthy nonpatients. Emotion. 2006;6(2):180-192. doi:10.1037/1528-3542.6.2.180
18. Gard G. Body awareness therapy for patients with fibromyalgiaand chronic pain. Disabil Rehabil. 2005;27(12):725-728.doi:10.1080/09638280400009071
19. Rudwaleit M, van der Heijde D, Landew&eacute; R, et al. Thedevelopment of Assessment of SpondyloArthritis internationalSociety classification criteria for axial spondyloarthritis (part II):validation and final selection. Ann Rheum Dis. 2009;68(6):777-783. doi:10.1136/ard.2009.108233
20. Hawker GA, Mian S, Kendzerska T, French M. Measures of adultpain: Visual Analog Scale for Pain (VAS Pain), Numeric RatingScale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ),Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic PainGrade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36BPS), and Measure of Intermittent and Constant OsteoarthritisPain (ICOAP). Arthritis Care Res (Hoboken). 2011;63 Suppl11:S240-252. doi:10.1002/acr.20543
21. Mayer TG, Neblett R, Cohen H, et al. The development andpsychometric validation of the central sensitization inventory. PainPract. 2012;12(4):276-285. doi:10.1111/j.1533-2500.2011.00493.x
22. D&uuml;zce Keleş E, Birtane M, Ekuklu G, et al. Validity andreliability of the Turkish version of the central sensitizationinventory. Arch Rheumatol. 2021;36(4):518-526. doi:10.46497/ArchRheumatol.2022.8665
23. Karaca S, Bayar B. Turkish version of body awarenessquestionnaire: validity and reliability study. Turk J PhysiotherRehabil. 2021;32(1):44-50.
24. Mukaka MM. Statistics corner: A guide to appropriate useof correlation coefficient in medical research. Malawi Med J.2012;24(3):69-71.
25. Hider S, Wong M, Ortiz M, Dulku A, Mulherin D. Does a regularexercise program for ankylosing spondylitis influence bodyimage? Scand J Rheumatol. 2002;31(3):168-171.
26. Buke M, Cetisli-Korkmaz N, Basakci-Calik B, Karasu U. TheAssociation of Physical Activity Level with Body Awareness andBalance in Individuals with Ankylosing Spondylitis. AktuelleRheumatol. 2023. doi:10.1055/a-2085-2204.
27. Ward MM. Health-related quality of life in ankylosing spondylitis:a survey of 175 patients. Arthritis Care Res. 1999;12(4):247-255.
28. Karaca N, Kinikli G, Sezer S, Keleşoğlu B, Kinikli G. POS1589-HPR High disease activity has a negative effect on paincatastrophizing, fear avoidance and body awareness levels inpatients with ankylosing spondylitis&mdash;a preliminary study. AnnRheum Dis. 2023;82:1170.
29. Guler MA, Celik OF, Ayhan FF. The important role of centralsensitization in chronic musculoskeletal pain seen in differentrheumatic diseases. Clin Rheumatol. 2020;39(1):269-274.doi:10.1007/s10067-019-04749-1
30. Aykurt Karlıbel I, Kasapoğlu Aksoy M. The relationship betweencentral sensitization and disease activity, quality of life, and sleepquality among patients with axial spondyloarthritis. Ir J Med Sci.2023;192(1):481-489. doi:10.1007/s11845-022-02957-4
31. Sariyildiz A, Coskun Benlidayi I, Turk I, Zengin Acemoglu SS, UnalI. Biopsychosocial factors should be considered when evaluatingcentral sensitization in axial spondyloarthritis. Rheumatol Int.2023;43(5):923-932. doi:10.1007/s00296-023-05317-2
32. Kieskamp SC, Paap D, Carbo MJG, et al. Central sensitizationhas major impact on quality of life in patients with axialspondyloarthritis. Semin Arthritis Rheum. 2022;52:151933.doi:10.1016/j.semarthrit.2021.11.006
Volume 6, Issue 5, 2023
Page : 1022-1028
_Footer